Marshall Wace North America’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-47,800
Closed -$329K 1344
2020
Q3
$329K Buy
+47,800
New +$359K ﹤0.01% 1052
2019
Q1
Sell
-115,267
Closed -$1.01M 1601
2018
Q4
$1.01M Buy
115,267
+70,565
+158% +$707K 0.01% 613
2018
Q3
$484K Buy
+44,702
New +$536K ﹤0.01% 708
2018
Q1
Sell
-284,657
Closed -$2.99M 1461
2017
Q4
$2.99M Sell
284,657
-260,826
-48% -$2.89M 0.02% 724
2017
Q3
$6.55M Buy
545,483
+501,504
+1,140% +$6.17M 0.04% 473
2017
Q2
$616K Buy
+43,979
New +$617K ﹤0.01% 1053

Other funds holding CLS

Marshall Wace North America's CLS Position: Q4 2020 in Review

Marshall Wace North America sold out of Celestica (CLS) in Q4 2020, closing a stake of 47,800 shares — an estimated $329K sold.

Marshall Wace North America first reported a position in CLS in Q2 2017 and held it in 6 quarters. The position peaked at $6.55M in Q3 2017. 117 funds tracked by Wall St. Rank hold CLS as of Q4 2020.

  • Marshall Wace North America reported no remaining Celestica position as of Q4 2020 after selling out during the quarter.
  • Marshall Wace North America sold 47,800 Celestica shares in Q4 2020, an estimated $329K.
  • Marshall Wace North America first reported a position in Celestica in Q2 2017 and held it in 6 quarters.
  • Marshall Wace North America's Celestica position peaked at $6.55M in Q3 2017.
  • 117 funds tracked by Wall St. Rank held Celestica as of Q4 2020.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.